OB Pharma is developing new molecules for the treatment of epilepsy and other seizure related disorders.
OB’s labs are located at the University of Western Ontario and the lab is operated by Dr. Michael Poulter PhD.
Dr. Poulter is one of the world’s preeminent scientists and experts in the field of epilepsy research.
OB Pharma is currently seeking venture partners to complete its preclinical program in order to file an IND with the U.S. FDA and a CTA with Health Canada and initiate clinical trials.
Coming Soon: Investor Update 2019